257 related articles for article (PubMed ID: 21416507)
21. Neutropenia induced by second generation antipsychotics: a prospective investigation.
Rettenbacher MA; Hofer A; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2010 Mar; 43(2):41-4. PubMed ID: 20175050
[TBL] [Abstract][Full Text] [Related]
22. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
23. Transient neutropenia induced by clozapine.
Hummer M; Kurz M; Barnas C; Fleischhacker WW
Psychopharmacol Bull; 1992; 28(3):287-90. PubMed ID: 1480732
[TBL] [Abstract][Full Text] [Related]
24. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
Maskasame S; Krisanaprakornkit T; Khiewyoo J
J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
[TBL] [Abstract][Full Text] [Related]
25. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
26. [Clozapine and agranulocitosis in Spain: do we have a safer population? A 5-year hematologic follow-up].
Pons A; Undurraga J; Batalla A; Bernardo M
Rev Psiquiatr Salud Ment; 2012; 5(1):37-42. PubMed ID: 22854502
[TBL] [Abstract][Full Text] [Related]
27. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
28. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?
Schulte PFJ; Veerman SRT; Bakker B; Bogers JPAM; Jongkind A; Cohen D
Schizophr Res; 2024 Jun; 268():74-81. PubMed ID: 37770377
[TBL] [Abstract][Full Text] [Related]
29. Clozapine re-challenge under the cover of Filgrastim.
Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of clozapine-induced granulocytopenia with lithium (two observations)].
Papetti F; Darcourt G; Giordana JY; Spreux A; Thauby S; Feral F; Pringuey D
Encephale; 2004; 30(6):578-82. PubMed ID: 15738861
[TBL] [Abstract][Full Text] [Related]
31. Ethnic neutropenia and clozapine.
Bray A
Aust N Z J Psychiatry; 2008 Apr; 42(4):342-5. PubMed ID: 18330777
[TBL] [Abstract][Full Text] [Related]
32. [Risk minimization evolution of agranulocytosis caused by the administration of pharmaceutical products containing Clozapine in Argentina].
Bergman M; Bignone I; Bisio A; Bologna V; Sabatini A
Vertex; 2011; 22(96):94-7. PubMed ID: 21977603
[TBL] [Abstract][Full Text] [Related]
33. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
[TBL] [Abstract][Full Text] [Related]
34. [Hematologic effects of clozapine: a review of the international experience].
Lamarque V
Encephale; 1996 Dec; 22 Spec No 6():35-6. PubMed ID: 9102319
[TBL] [Abstract][Full Text] [Related]
35. Comment on "lithium and clozapine rechallenge: a retrospective case analysis".
Esposito D
J Clin Psychiatry; 2007 Apr; 68(4):635; author reply 635. PubMed ID: 17474825
[No Abstract] [Full Text] [Related]
36. White blood cell monitoring during long-term clozapine treatment.
Cohen D; Monden M
Am J Psychiatry; 2013 Apr; 170(4):366-9. PubMed ID: 23545791
[TBL] [Abstract][Full Text] [Related]
37. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
38. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
Herceg M; Muzinić L; Jukić V
Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
[TBL] [Abstract][Full Text] [Related]
39. [Clozapine screening: white bloodcell counts no longer sufficient].
Cohen D;
Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
[TBL] [Abstract][Full Text] [Related]
40. Continuing clozapine treatment despite neutropenia.
Esposito D; Rouillon F; Limosin F
Eur J Clin Pharmacol; 2005 Jan; 60(11):759-64. PubMed ID: 15660271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
